DE2164847C3 - l-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung - Google Patents
l-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner HerstellungInfo
- Publication number
- DE2164847C3 DE2164847C3 DE2164847A DE2164847A DE2164847C3 DE 2164847 C3 DE2164847 C3 DE 2164847C3 DE 2164847 A DE2164847 A DE 2164847A DE 2164847 A DE2164847 A DE 2164847A DE 2164847 C3 DE2164847 C3 DE 2164847C3
- Authority
- DE
- Germany
- Prior art keywords
- hydroxybutoxy
- hydroxybutane
- preparation
- solution
- butanediol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- FYFRDDSKFFFGCU-UHFFFAOYSA-N 1-(3-hydroxybutoxy)butan-2-ol Chemical compound OC(COCCC(C)O)CC FYFRDDSKFFFGCU-UHFFFAOYSA-N 0.000 title description 3
- 238000000034 method Methods 0.000 title description 3
- 238000002360 preparation method Methods 0.000 title description 2
- -1 2-Hydroxybutoxy Chemical group 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- LGCMKPRGGJRYGM-UHFFFAOYSA-N Osalmid Chemical compound C1=CC(O)=CC=C1NC(=O)C1=CC=CC=C1O LGCMKPRGGJRYGM-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000004508 fractional distillation Methods 0.000 description 3
- 229950011258 osalmid Drugs 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000008845 cholagoga Substances 0.000 description 2
- 229940124571 cholagogue Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
- C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP45124208A JPS4920290B1 (enrdf_load_stackoverflow) | 1970-12-31 | 1970-12-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2164847A1 DE2164847A1 (de) | 1972-08-03 |
| DE2164847B2 DE2164847B2 (de) | 1973-02-15 |
| DE2164847C3 true DE2164847C3 (de) | 1973-09-13 |
Family
ID=14879653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2164847A Expired DE2164847C3 (de) | 1970-12-31 | 1971-12-27 | l-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS4920290B1 (enrdf_load_stackoverflow) |
| DE (1) | DE2164847C3 (enrdf_load_stackoverflow) |
| FR (1) | FR2120143B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1337353A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5312982U (enrdf_load_stackoverflow) * | 1976-06-26 | 1978-02-02 |
-
1970
- 1970-12-31 JP JP45124208A patent/JPS4920290B1/ja active Pending
-
1971
- 1971-12-27 DE DE2164847A patent/DE2164847C3/de not_active Expired
- 1971-12-30 GB GB6075371A patent/GB1337353A/en not_active Expired
- 1971-12-30 FR FR7147486A patent/FR2120143B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1337353A (en) | 1973-11-14 |
| DE2164847B2 (de) | 1973-02-15 |
| JPS4920290B1 (enrdf_load_stackoverflow) | 1974-05-23 |
| DE2164847A1 (de) | 1972-08-03 |
| FR2120143B1 (enrdf_load_stackoverflow) | 1975-08-01 |
| FR2120143A1 (enrdf_load_stackoverflow) | 1972-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1720020B2 (de) | 1- eckige Klammer auf alpha-(N-o-Chlorbenzyl)-pyrryl eckige Klammer zu -2-di-sec-burylamino-äthanol, dessen Säureadditionssalze und Verfahren zu seiner Herstellung | |
| DE1445186B2 (de) | 3,3'-Di-2-imidazolin-2-yl-carbanilid | |
| DE2164847C3 (de) | l-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung | |
| DE2164997C3 (de) | 2-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung | |
| DE2817923A1 (de) | Septacidinverbindungen und diese enthaltende arzneimittel | |
| DE2207460C2 (de) | Verwendung von Hydroxycylohexylaminderivaten bei der Behandlung von ödematös atelektatischen Lungenveränderungen | |
| DE2163000B2 (de) | (Piperidin-4-spiro)-5-oxazolidone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
| DE2224539C3 (enrdf_load_stackoverflow) | ||
| DE3486237T2 (de) | Herstellung von Diacetoxybenzylidendiacetaten. | |
| DE801839C (de) | Verfahren zur Herstellung eines organischen Salzes der ª-Methylmercapto-ª-aminobuttersaeure | |
| DE1129490B (de) | Verfahren zur Herstellung des N-(5-Nitro-2-furfuryliden)-3-amino-3, 4, 5, 6-tetrahydro-1, 3-oxazinons-(2) | |
| DE1643570C3 (de) | l-(3,5-Dimethoxy-4-hydroxyphenyl)-2-monomethylaminoäthanol enthaltende Arzneimittel | |
| DE1215719B (de) | Verfahren zur Herstellung einer Molekuelverbindung des Coffeins | |
| DE1493078C3 (de) | Lävulinsäure- und Chlorbenzoesäureamidderivale des 2-Aminomethyl-3-methylnorbornans, ihre Herstellung und sie enthaltende Arzneimittel | |
| DE1795125C (de) | Chinolinderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE1175241B (de) | Verfahren zur Herstellung von Salzen des 2-Aminothiazolins | |
| DE1802162C (de) | N-(2-Methyl-3-hydroxy-5-hydroxymethyl-4-pyridylmethyliden)-homocysteinthiolacton, dessen Säureadditionssalze sowie Verfahren zu ihrer Herstellung | |
| DE1695998C3 (de) | N hoch 2, N hoch 3-Di-spiro-tripiperazlnium-salze und Verfahren zu ihrer Herstellung | |
| DE1468681C3 (de) | 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel | |
| DE1162850B (de) | Verfahren zur Herstellung therapeutisch wirksamer geschmackloser Kohlensaeureester des Chloramphenicols | |
| DD246799A1 (de) | Verfahren zur herstellung von salzen aus (beta)(p-n,n-bis-(2-chlor-ûthyl)-amino-phenyl)-n-acetyl-(alpha)-alanin und 1-methylamino-1-desoxy-polyolen | |
| DE1133382B (de) | Verfahren zur Herstellung von 2-Methyl-5-(ª‰-trimethylammonium-aethoxy)-8-methoxy-furo-(4', 5':6, 7)-chromon-theophyllinat | |
| DE1620200B2 (de) | 7 Oxo desacetamido colchicin derivate, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel Ausscheidung aus 1235322 | |
| DE1051842B (de) | Verfahren zur Herstellung von AEthyl-N-bis-(2-chlorpropyl)-carbamat | |
| DE1153204B (de) | Mittel zur Bekaempfung von Insekten und Spinnentieren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E771 | Valid patent as to the heymanns-index 1977, willingness to grant licences | ||
| EHJ | Ceased/non-payment of the annual fee |